Build my stack
Home · Guides · Retatrutide Price

Retatrutide Price Today: Cost per mg at Every Vendor We Review

Read this first. Retatrutide is an investigational drug. No approved retatrutide product exists anywhere in the world, so there is no pharmacy price, insurance price or list price to quote. Lilly, which is developing it, says it "has not been reviewed or approved by the FDA or any regulatory agency in the world, and no one can legally sell it for human use." The prices below are what online stores charge for vials labelled for research use. FDA says such labels are false on products sold as drugs and that it "urges consumers not to purchase these products which are of unknown quality and may be harmful to their health." Nothing on this page means a vial is safe for a person.
Disclosure: affiliate links below may earn the Bureau a commission at no cost to you.

Short answer: on 21 November 2026 research-labelled retatrutide vials listed from $2.83 per mg (Luvaminos, 30 mg for $85.00) to $6.90 per mg (Aurelia Research (US store), 10 mg) across the 3 vendors the Bureau reviews that list it, before any discount code. At every one of them the bigger vial is the cheaper one per mg. A 30 mg vial ran from $85.00 at Luvaminos to $189.99 at Amino Club.

Go to Luvaminos through the Bureau's partner link. Code PEPTIDEBUREAU: lower set prices on every single vial.

Retatrutide price today, by vendor

Vendor (Bureau score)VialPricePer mgReader deal
Luvaminos (4.1, no independent test held)10 mg$40.00$4.00Code PEPTIDEBUREAU: lower set prices on every single vial (our link applies it)Check price
20 mg$65.00$3.25
30 mg$85.00$2.83 lowest today
60 mg (out of stock)$145.00$2.42
Aurelia Research (US store) (3.8, no independent test held)10 mg$68.99$6.9015% off a first order, applied automatically through our linkCheck price
20 mg$114.99$5.75
30 mg$149.49$4.98
Amino Club (4.7, 0 of 1 independent tests passed)10 mg$64.99$6.50Code 100: 20% offCheck price
20 mg$126.99$6.35
30 mg$189.99$6.33

List prices read from each vendor's own store data on 21 November 2026, before any code. Vendors are ordered by their lowest in-stock price per mg and nothing else. Check price links are affiliate links: the Bureau earns a commission at no cost to you. Limitless Life Peptides, OMNI Peptides and Southern Aminos show prices only after a login or an access request, so they are not in the table. The store data for Apollo Peptide Sciences, Amino USA and Direct Peptides (directpeptides.com) did not answer on 21 November 2026; it comes back on the next read that works. Pantheon Peptides, Ascension Peptides, Sports Technology Labs, Peptide Partners, Penguin Peptides and Ion Peptides listed no single retatrutide vial the Bureau could price on 21 November 2026. These are vials sold for research use, not a pharmacy product, and a listing here is not a statement that a product is safe for people.

Cheapest price per mg at each vial size

VialLowest pricePer mgAtVendors listing it
10 mg$40.00$4.00Luvaminos3
20 mg$65.00$3.25Luvaminos3
30 mg$85.00$2.83Luvaminos3

How to read these prices

Price per mg is the list price divided by the milligrams on the label: 30 mg for $85.00 is $2.83 per mg at Luvaminos today. It is the only fair way to compare vials of different sizes. It assumes the label is right, and that is the part a price cannot tell you.

Some stores do not print the name on the product. Amino Club lists it as AMP-3 (RT), Luvaminos as Luv RT, Aurelia Research as AR-RTA and Apollo as GLP-3 R; the Bureau's reviews tie those codes to the compound. Lilly calls "GLP-3" a "scientifically inaccurate label" for what it describes as a triple agonist, so read a code as a store's product name and nothing more.

This page gives no dosing advice. For vial arithmetic, use the retatrutide calculator at Peptulator. Every other compound the Bureau tracks is on the peptide price tracker.

A low price says nothing about what is in the vial

Lilly's warning on products sold outside its trials is specific: they "may contain unknown ingredients, harmful contaminants and impurities" and "may also have too much or too little active ingredient, or the wrong ingredient entirely." In Australia, the regulator's laboratory found that a product labelled retatrutide, used by a patient who suffered a torn oesophagus, contained no retatrutide and undeclared semaglutide, ABC News reported.

Independent test records are thin at the prices above. Finnrick, a third-party testing site, read on 2 November 2026, rated retatrutide from Amino Club at 74% and from Apollo at 74%, each on one test, and showed no rated retatrutide tests for Luvaminos. The full comparison, including the stores with the longest records, is on where to buy retatrutide. A Bureau score rates a store from the desk on its documents, shipping, service, price and longevity; independent tests are shown beside it, not inside it. It is not a lab result on any vial.

Not sure which of these you actually need?

Answer five questions about your goal, experience and budget and the Stack Builder shows you a matched research protocol on screen, with the compounds and vendor picks from the vendors we score.

Build your stack, 2 minutes

What an approved drug costs, for comparison

Tirzepatide, a different drug from the same company, is approved and has real prices: Lilly's own pharmacy listed Zepbound for self-pay from $299 to $449 a month on 2 November 2026, on a prescription. Those are the prices of a reviewed medicine, and they are not a like for like comparison with a research vial. The routes and terms are on tirzepatide cost. Whether any medicine suits you is a question for a prescriber.

What retatrutide will cost if it is approved

Nobody can say yet, and any figure you see is a guess. Lilly's only statement is that "upon completion of clinical trials and the regulatory review process, we plan to ensure retatrutide is priced to reflect the overall value to the healthcare system." On 29 September 2026 it said it "plans to submit a Biologics License Application (BLA) in Q1 2027" to FDA. A filing is not an approval, and Lilly says launch depends on completing the trials and the regulatory process.

What regulators and Lilly say about these sales

  • FDA on compounding: "Retatrutide and cagrilintide cannot be used in compounding under federal law."
  • FDA on research labels: it has warned companies that illegally sold unapproved drugs containing semaglutide, tirzepatide, retatrutide, survodutide or mazdutide falsely labelled "for research purposes" or "not for human consumption".
  • Lilly on sales to consumers: "FDA has made clear that sales of unapproved retatrutide to consumers are illegal". Lilly filed six lawsuits against US sellers in August 2026, and Bloomberg Law reported five more on 8 October. These are allegations.
  • Harm reports: our report on the black market covers the two deaths reported to FDA, where causation is unverified, and the rise in poison center calls.

The Bureau reports these prices as a record of a research-chemical market, not as advice to use the product. The wider legal picture is in the research peptides legal status guide.

Reader deals at the stores in the table

Links may earn the Bureau a commission at no cost to you; that is not an input to any score. The order of stores in our buying blocks, including the Best vendor label, is our own choice and is not the score; some of those stores pay us commission. A code changes the price, not what is in the vial. Research use only.

Every compound, every morning: the peptide price tracker. Working codes: peptide coupon codes. How stores are scored: the 2026 scorecard.

Vendor Watch · free

Know before you order: an email when a vendor we cover is shut down, seized, fails a lab test or changes its code.

Plus, every Friday, the week's lowest price per mg for each compound at the vendors we score, all of which publish batch COAs. Your 5-minute vendor check sheet opens as soon as you confirm.

Every alert is checked by a person and cites its source before it is sent. One-click unsubscribe. Research use only.

Frequently Asked Questions

What is the price of retatrutide today?

On 21 November 2026 the lowest in-stock price among the vendors the Bureau reviews was $2.83 per mg (Luvaminos, 30 mg for $85.00) and the highest was $6.90 per mg (Aurelia Research (US store), 10 mg for $68.99). These are list prices before any code for vials labelled for research use, read from each store's own data.

Is there a pharmacy or insurance price for retatrutide?

No. Retatrutide is investigational and no approved product exists anywhere in the world, so there is no prescription, pharmacy, insurance or manufacturer price. Lilly says it is not on the market and that no one can legally sell it for human use.

How much will retatrutide cost once it is approved?

No one can say yet. Lilly says only that it plans to price it to reflect the overall value to the healthcare system once trials and regulatory review are complete. On 29 September 2026 Lilly said it plans to file for FDA approval in the first quarter of 2027, and a filing is not an approval.

Why do retatrutide prices differ so much between stores?

The Bureau can show the gap but not explain it: a store's price per mg does not tell you what is in its vial. Independent test records for the stores in the table are thin, and Lilly warns that products sold outside its trials may hold too much, too little or the wrong ingredient.

Is a cheap research vial of retatrutide safe for people?

No one can say that a vial is. These vials are sold for research use and have not been reviewed by any regulator. FDA urges consumers not to purchase such products, which it says are of unknown quality and may be harmful to their health.

Do discount codes work on retatrutide?

Some do. The table shows the reader deals the Bureau tracks for each store, such as Amino Club's code 100 and code PEPTIDEBUREAU at Luvaminos and PSPeptides. All prices on this page are before any code.Checkout paused since 20 Nov 2026; the store says orders reopen soon.

Sources

  1. Lilly, What to know about retatrutide, updated October 2026. Read 2 November 2026.
  2. Lilly, Lilly calls on online platforms, payment companies and regulators to shut down the illegal retatrutide black market, 12 August 2026. Read 2 November 2026.
  3. Lilly, TRIUMPH-2 results and BLA plan, 29 September 2026. Read 2 November 2026.
  4. FDA, FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss, content current as of 1 October 2026. Read 2 November 2026.
  5. ABC News, Patient suffers torn oesophagus after using unapproved peptide, 14 September 2026.
  6. Bloomberg Law, Eli Lilly sues more vendors selling illicit weight-loss drugs, October 2026.
  7. Finnrick vendor pages for Amino Club, Apollo Peptide Sciences and LUV Aminos. Read 2 November 2026.
  8. Lilly, Zepbound on LillyDirect. Read 2 November 2026.
  9. Peptide Bureau daily price tracker, list prices read 21 November 2026, before any code.
PB
The Peptide Bureau editorial desk. Peptide Bureau is a small independent research team covering peptide dosing, safety and vendors. We are not clinicians; nothing here is medical advice. How the Bureau works.